celecoxib has been researched along with levosulpiride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aldib, I; Chikh Alard, I; De Carvalho, A; Dufrasne, F; Flemmig, J; Furtmüller, PG; Gelbcke, M; Mathieu, V; Meyer, F; Nève, J; Obinger, C; Prévost, M; Rousseau, A; Soubhye, J; Tadrent, S; Van Antwerpen, P; Zouaoui Boudjeltia, K | 1 |
2 other study(ies) available for celecoxib and levosulpiride
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
Topics: Benzimidazoles; Cell Line; Databases, Chemical; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutamic Acid; Glutamine; Guanidines; Humans; Hydrogen Peroxide; Kinetics; Lactoperoxidase; Lipoproteins, LDL; Models, Chemical; Molecular Docking Simulation; Neutrophils; Oxidation-Reduction; Peroxidase; Quinazolines; Stereoisomerism | 2017 |